Discrepancy between self-reported and actual caloric intake NEJM
Pregnancy and Breastfeeding Safety Spironolactone should never be used during pregnancy , as it poses serious risks to fetal development
We observed that many signature genes completely lack, or have very little, NRF2 ChIP-seq signal within 1 kb of their promoter (Fig
Everyone deserves compassionate, science-backed care that acknowledges the challenges of obesity and provides effective, sustainable solutions
The observed differences in weight loss and metabolic outcomes across agents underscore the importance of individualized treatment selection, considering patient characteristics, tolerability, dose escalation, dosing feasibility, and overall treatment goals
The article lists crystallisation, cloudiness, discoloration, particles, and separation of layers in the vial as signs that molecular breakdown may have begun